10% off on every stack, always. 5 · 7.5 · 10% off on 3, 6 or 9 of the same vial. Same-day dispatch on orders before 12:00 SAST, business days.

◂ RESEARCH LIBRARY
Tirzepatide research peptide

Research Overview

Tirzepatide

Effortless Appetite Control

HPLC-verified 98%Batch CoAResearch use only

AVAILABLE SIZES

10 mg30 mg

OVERVIEW

Tirzepatide (Effortless Appetite Control) is a research-grade peptide supplied by Living Water Labs for laboratory investigation. Dual-action peptide that curbs cravings and drives steady weight loss. Each batch is HPLC-verified to a minimum 98% purity with a batch-specific Certificate of Analysis. The summary below outlines documented mechanisms and study areas reported in the research literature.

Scientific name

LY3298176 (GIP/GLP-1 Receptor Dual Agonist)

Molecular weight

4813.5 g/mol

Purity

99.1%

Vial size

10mg

DOCUMENTED RESEARCH AREAS

  • Strong appetite suppression
  • Steady, consistent weight loss
  • Better blood sugar control
  • Longer-lasting fullness
  • Reduced food cravings
  • Improved metabolic health

MECHANISM OF ACTION

Tirzepatide is a synthetic dual agonist of the GIP and GLP-1 incretin receptors. By engaging both receptors it is reported to enhance glucose-dependent insulin secretion and reduce appetite, and it has been evaluated in large clinical trials for glycaemic and weight endpoints.

  • Dual agonist of the GIP and GLP-1 incretin receptors
  • Enhances glucose-dependent insulin secretion in studies
  • Evaluated in large phase-3 clinical trials for metabolic endpoints

STUDY SUMMARIES

3 peer-reviewed references

Mol Metab · 2018

LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept

The discovery-to-proof-of-concept study characterising LY3298176 (tirzepatide) as a novel dual GIP/GLP-1 receptor agonist.

View on PubMed (PMID 30473097)

N Engl J Med · 2021

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

In a head-to-head phase-3 trial, tirzepatide was compared with once-weekly semaglutide for glycaemic control in type-2 diabetes.

View on PubMed (PMID 34170647)

N Engl J Med · 2022

Tirzepatide Once Weekly for the Treatment of Obesity

In the SURMOUNT-1 phase-3 trial, tirzepatide produced substantial dose-dependent body-weight reduction over 72 weeks.

View on PubMed (PMID 35658024)

CITATIONS

  1. 1.LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Mol Metab. 2018. PMID 30473097. pubmed.ncbi.nlm.nih.gov/30473097
  2. 2.Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021. PMID 34170647. pubmed.ncbi.nlm.nih.gov/34170647
  3. 3.Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022. PMID 35658024. pubmed.ncbi.nlm.nih.gov/35658024

Citations describe findings reported in the referenced preclinical, in-vitro or clinical literature. They are provided for research and educational purposes only and are not a therapeutic claim.

All information is provided for research and educational purposes only and describes findings in preclinical/in-vitro literature. Not medical advice. Products are supplied strictly for research purposes — not for human consumption.

Related Research & Reading

Keep exploring — goal collections, plain-language guides and the wellness journal, all in one place.

Research Axes · 22 Goals

Shop by Goal

Start from what you want to change rather than from a compound name. Every goal below opens a full vertical — what the research points to, what we stock for it, and how to run it.

Browse all goals →

Health & Longevity

Systemic wellness — the compounds most studied for how you age, recover overnight and feel day to day.

Performance & Repair

Training, recovery and tissue-repair research — for getting back to the gym, the field or the trail sooner.

By Concern

Start from what you want to change — skin, hair, focus, mood, libido — and see what research points to.

Who It’s For

Curated entry points for specific researchers — women, veterinary work, first-timers and bulk buyers.

HPLC Verified · CoA On Every Batch · Nationwide Delivery